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Collagenase-3 (matrix metalloproteinase 13, MMP-13)
was employed as a surrogate marker to compare the
characteristics of incisional wound repair after surgery
with the free-electron laser at 6.1 lm and the scalpel.
Using a transgenic mouse strain with the MMP-13 or
the COL1A2 promoter driving luciferase expression,
we observed MMP-13 and COL1A2 expression, tensile
strength, macrophage in¢ltration, and wound histology
for up to 62 d. The scalpel incisions showed higher ten-
sile strength than free-electron laser wounds from days
10 to 22 postwounding, despite minimal collateral ther-
mal damage. After 45 d healing was similar. Trichrome
staining con¢rmed that the scalpel incisions had more
dense collagen deposition than free-electron laser inci-
sions up to 36 d postinjury, but at day 45 they became
similar. MMP-13 expression was biphasic, with peak ac-
tivities at days 15 and 37 after injury, whereas free-
electron laser wounds showed greater luciferase activity
than scalpel wounds. Peak COL1A2 activity preceded
the MMP-13 maximum. MMP-13 expression localized
predominantly to dermal ¢broblasts near the epidermis
at day 15, and in the region of the deep dermis, muscle,
and fascia at day 37 postwounding. Migrating muscle
cells, but not all skeletal muscle cells, also expressed
MMP-13. Free-electron laser incisions contained more
macrophages than scalpel wounds at days 2 and 7 post-
injury, suggesting that free-electron laser irradiation
exacerbated the in£ammatory response and thereby sti-
mulated MMP-13 expression. These results revealed that
MMP-13 was involved in a series of coordinated events
during wound healing, not only the long-term remo-
deling of wound connective tissue, but also skeletal
muscle repair. MMP-13 activity in vivo may correlate
with the extent of tissue damage. Key words: collagenase/
free-electron laser/luciferase/MMP-13/wound healing. J Invest
Dermatol 121:926 ^932, 2003
L
aser techniques have been used in a variety of surgical
applications and have proved to be a versatile and reli-
able tool.When the laser beam is focused, it can incise
tissue in a fashion similar to a sharp blade but with
improved hemostasis and controlled depth of injury
without direct contact (Nemeth, 1993; Izzo et al, 2001). Lasers in
general, however, have the disadvantage of causing a delay in
wound healing compared with scalpel incisions due to collateral
damage (Molgat et al, 1995). Currently, the CO2 laser is the most
commonly used laser for tissue ablation and incision. The inci-
dental, collateral thermal damage associated with the laser is in-
disputable, however, attributable to the direct e¡ects of thermal
energy penetrating unintended tissues (Speyer et al, 1996; Bryant
et al, 1998). Consequently, researchers have attempted to modify
the pulse structure of the CO2 laser to minimize this thermal in-
jury and thus reduce wound-healing delays (Bryant et al, 1998).
Some improvements have been gained, but the healing delays re-
main signi¢cant (Sanders and Reinisch, 2000).
The Vanderbilt free-electron laser (FEL) is a pulsed infrared
laser that is tunable over a wavelength range from 2 to 9 mm
(Bryant et al, 1998). This laser has been shown to ablate tissue
e⁄ciently with minimal collateral thermal damage in various
tissues, in particular when tuned to a wavelength of 6.45 mm (peak
absorption band for the amide II protein bond) (Edwards et al,
1994). At this wavelength, about 50% of the light is absorbed by
the structural proteins and 50% of the light is absorbed by water.
Previous studies (Peavy et al, 1999; Payne et al, 2001) have also de-
monstrated that the FEL beam with wavelengths in the 6.1 mm
(amide I) to 6.45 mm (amide II) region, when delivered by a com-
puter-controlled delivery system, showed clean, deep cortical
bone ablations with minimal collateral thermal damage. Thus,
the pulsed infrared energy produced by the FEL at speci¢c wave-
lengths and targeted to speci¢c dermal proteins rather than non-
speci¢c water absorption could reduce lateral thermal damage.
The CO2 laser emits infrared light with a wavelength of 10.6 mm
and is absorbed by tissue with high water content. The penetra-
tion depth in tissue depends on the amount of water in the tissue
(Bryant et al, 1998). The water in target tissue absorbs this energy
and is vaporized, resulting in thermal ablation. Furthermore, the
CO2 laser is essentially a continuous-wave laser, whereas the FEL
is a pulsed laser with a 5 ms pulse length that allows for thermal
dissipation. Theoretically, FEL incisions at appropriate wave-
lengths should produce less collateral tissue damage by tuning to
wavelengths that target structural proteins in the tissue. Prelimin-
ary studies in the rat had suggested that incisional wound healing
was superior in FEL-incised wounds (Davidson et al, 2001).
With these characteristics in mind, we compared the wound
healing of incisions in mouse skin created by the FEL with a
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wavelength of 6.1 mm to incisions created by a conventional
scalpel.We determined how the wound healing of FEL and scal-
pel incisions correlated with matrix metalloproteinase (MMP-13)
expression by quantitative in vivo observation of MMP-13 and
COL1A2 transcription in transgenic reporter mice during wound
repair.
MATERIALS AND METHODS
Animal model All the procedures using the animals were conducted in
compliance with state and federal guidelines and approved by the
Vanderbilt University Institutional Animal Care and Use Committee. In
this study, the transgenic mice in which the MMP-13 promoter drives the
luciferase reporter gene were made by our laboratory and have been
described in detail previously (Wu et al, 2002). The collagen transgenic
mice in which collagen (COL1A2) type I promoter drives luciferase
and b-galactosidase gene were produced in the laboratory of B.
Crombrugghe, MDAnderson Cancer Center, Houston,TX (Bou-Gharios
et al, 1996).
Scalpel and FELwounds Mice were anesthetized with iso£urane in an
iso£urane vaporizer (Ohmeda, BOC Health Care, UK). After the mice
were sedated, the dorsal fur was removed using a clipper. Two full-
thickness longitudinal incisions, separated by 1.5 cm and each 1.0 cm in
length, were made on the dorsal skin of each mouse. The ¢rst lesion was
made using a standard #10 surgical scalpel. The second lesion was
produced using the FEL. The laser was operated at a wavelength of 6.1
mm in 5 ms micropulses, with a pulse energy of 20 mJ and 30 Hz
repetition rate (Izzo et al, 2001). The laser beam was delivered with
a Computer Assisted Surgical Technique system (Reinisch et al, 1994).
The pattern for the incisions was a straight line. The computer was
programmed to create the incision by scanning the beam in a random,
stepwise fashion until the line was complete. The pattern was repeated
until the full-thickness wound was obtained. Finally, the wounds were
closed using two 3^0 Ethilon (Ethicon, Somerville, NJ) sutures.
Following the surgery, mice were given supplemental heat and allowed to
recover fully in the animal care facility without any restrictions. At
di¡erent time points, the transgenic mice were imaged for luciferase
activity under anesthesia and returned to their cages, whereas the wild-
type mice were euthanized and used to determine wound tensile strength.
Tensile strength measurement Wild-type male mice (C57/BL6) were
used for a wound healing study. Tensiometry was performed on the
skin incisions using the Instron 5542 tensiometer (Instron, Canton, MA)
within 3 h after tissue harvest (Benn et al, 1996). All tensiometry was
performed in a blinded fashion. The incision was harvested immediately
after the animal was euthanized. A small portion of incision was placed in
4% paraformaldehyde and then embedded in para⁄n, and the sections
were used for immunohistochemistry. The rest of each tissue strip
(approximately 0.5 cm of incision) was oriented in the jaws of the
tensiometer perpendicular to the line of the incision. Peak breaking forces
were measured and converted to tensile strength values (kilogram force per
square centimeter) by dividing the breaking force by the cross-sectional
area of the tissue that broke. The thickness of the specimen was assumed
to be constant for all specimens. Data were reported as mean7SD and
compared using the Student’s t test.
Bioluminescence imaging in living animals Luciferase images were
taken as previously described (Wu et al, 2002). Brie£y, mice were
anesthetized by intraperitoneal injection of a mixture of ketamine and
xylazine and were administered liquid luciferase substrate topically,
luciferin (30 mL per wound, 16 mg per mL in dimethylsulfoxide
(DMSO)), onto wounds and unwounded skin (Contag et al, 1997). The
animals were placed in a light-tight imaging chamber after 5 min. A
gray-scale, body-surface reference image (Sweeney et al, 1999) and a
pseudocolor image representing light intensity were collected with the
Hamamatsu Intensi¢ed Charged Coupled Device (ICCD) camera
(Hamamatsu Photonics, Hamamatsu City, Japan). Gray-scale reference
images and pseudocolor images were superimposed by using the image-
processing software (Hamamatsu). Total, maximum, and average photon
emissions from unwounded skin and wound sites within the images of
each mouse were quanti¢ed with Argus50 software (Hamamatsu).
Background values from unwounded skin that had been treated with
luciferase/DMSO were subtracted from wound signals. The luciferase/
DMSO solution did not produce local irritation.
In situ hybridization analysis Mouse skin tissue was subjected to in situ
hybridization using digoxigenin-labeled riboprobes as described previously
(Ho¡ et al, 1999). Brie£y, mouse skin was ¢xed in 4% paraformaldehyde
and then embedded in para⁄n. Sections were cut and depara⁄nized in
xylenes and hydrated through graded ethanols to phosphate-bu¡ered
saline (PBS). Tissue was ¢xed in 4% paraformaldehyde before and after
treatment with proteinase K (Sigma, St Louis, MO; 20 mg per mL, in 100
mM Tris pH 8.0, 50 mM ethylenediamine tetraacetic acid (EDTA), 20 min
at 371C). Following acetylation with 0.5% acetic anhydride, tissue was
dehydrated through graded ethanols and air-dried prior to hybridization.
Tissue sections were hybridized at 551C with digoxigenin-labeled mouse
MMP-13 riboprobes (antisense and sense) in a humid chamber. Slides
were washed in 50% formamide/2 sodium citrate/chloride bu¡er at
651C and 371C, digested with RNase A (20 mg per mL RNase A;
Clontech, Palo Alto, CA) in TNE bu¡er (10 mM Tris pH 7.5, 5 mM
EDTA, 0.5 M NaCl) at 371C for 30 min, and then washed in TNE at
551C. The digoxigenin detection procedure was carried out using the
GeniusTM3 kit (Boehringer Mannheim, Mannheim, Germany)
according to the manufacturer’s instruction. The antidigoxigenin antibody
was used at a 1:500 dilution, and the color reaction was allowed to proceed
until development was determined to be su⁄cient. Slides were
counterstained with 1% fast green FCF in distilled water for 1^2 min.
Immunohistochemistry Immunohistochemistry was performed as
previously described (Uria et al, 1998). Brie£y, sections (5 mm) were placed
in PBS containing 3% hydrogen peroxide (vol/vol) to inhibit endogenous
peroxidase activity. After blocking nonspeci¢c protein binding with 5%
goat serum in PBS, sections were incubated with diluted primary
antibody, followed by biotin-conjugated secondary antibody. StreptAB-
complex/horseradish peroxidase complex (Dako) was used to visualize the
staining. Sections were counterstained with hematoxylin. For negative
controls, the primary antibody was replaced by rat IgG (for macrophage)
or rabbit IgG (for MMP-13). Rat monoclonal antibody raised against
mouse macrophage (F4/80 antigen; Serotec, Oxford, UK) was used for
macrophage detection, and rabbit polyclonal antibody against MMP-13
(Biomol Research Laboratory, Plymouth Meeting, PA) was used for
mouse MMP-13 immunostaining. Secondary antibodies were biotin-
conjugated goat antirat IgG and goat antirabbit IgG, respectively.
Histologic study Tissue sections were stained with Masson’s trichrome
staining to evaluate collagen deposition. All tissue sections were stained en
masse to avoid variations in staining between specimens.
Basic ¢broblast growth factor (bFGF) administration in vivo Six-
week-old male transgenic mice were anesthetized, and the dorsal area was
shaved. The solution of human recombinant bFGF (a gift from Scios) in
PBS was mixed with a pluronic vehicle gel (Flow-gel Antiadhesion;
Synechion, Dallas, TX) at 01C. The mixture of 2 mg or 10 mg bFGF in
10 mL PBS and 50 mL pluronic gel was subcutaneously injected into intact
skin of the dorsal area. The control was given as a mixture of water and
pluronic vehicle. The luciferase image was taken at di¡erent time points
using the ICCD camera.
RESULTS
Tensiometry To compare the di¡erence in wound healing
between FEL and scalpel incisions, we measured the tensile
strength of full-thickness wound skin from normal mice (N¼ 5)
at days 10, 14, 22, 45, and 62 postwounding with a tensiometer.
The incisions made with the FEL were about 56% as strong as
those made with the scalpel at days 10, 14, and 22 after injury. At
day 45 after wounding, the tensile strength di¡erence between
FEL and scalpel incisions was reduced. The average tensile
strengths are plotted in Fig 1. Asterisks mark the tensile
strengths of scalpel wounds that were signi¢cantly stronger than
FEL incisions at the same time point (p¼ 0.05, p¼ 0.01).
Visualization of MMP-13 and collagen promoter activity
within FEL and scalpel wounds in transgenic mice
Transgenic male progeny 6^8 wk old (MMP-13 luciferase copy
number E50, collagen luciferase copy number E20) were used
to examine luciferase expression as a representation of MMP-13
promoter or collagen promoter activity during tissue repair.
Wounds were imaged for bioluminescence at di¡erent time
points after injury. Quantitation of bioluminescent signals was
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achieved by integrating the signal over time (3 min) and
reporting the data as total photon counts. As shown in Fig 2(A),
the MMP-13 promoter was dynamically active during wound
healing. Quanti¢cation of bioluminescence (photon counts)
indicated that the MMP-13/Luc signal showed an initial peak of
activity at day 15 after wounding. Surprisingly, there was a
second phase of gene activation with peak expression at day 37
after injury. The FEL incisions showed greater bioluminescent
luciferase activity than scalpel wounds during wound healing,
but the expression kinetics of MMP-13 promoter activity were
parallel in FEL and scalpel wounds. Among the individual mice
with FEL and scalpel wounds (N¼15), there was a very similar
pattern of luciferase expression. As shown in Fig 2(B), there was
only one expression peak in type I collagen (COL1A2) transgenic
mice during wound healing, and the peak expression of the
COL1A2 promoter was at 10 d after wounding; at 14 d
postinjury the promoter activity decreased dramatically and
almost no signal could be seen at 18 d after wounding. Thus,
collagen expression declined during the elevation of MMP-13
activity. Unwounded skin in transgenic animals and wounds in
nontransgenic animals did not produce a bioluminescent signal.
The tail, snout, and paw areas, however, appeared to show high
constitutive MMP-13 activity when systemic luciferin was used
(see Fig 7, later).
In situ hybridization To understand the temporal and spatial
distribution of MMP-13 mRNA in the transgenic mice after
injury, in situ hybridization was performed. Mice were sacri¢ced
at di¡erent time points after wounding, and the skin was ¢xed,
embedded, and sectioned. Digoxigenin-labeled riboprobes for
MMP-13 were hybridized to sections of mouse skin. The result
(Fig 3A) showed that MMP-13 transcripts were present in
dermal ¢broblasts of dermis adjacent to the epidermis, but not
in the keratinocytes, at day 15 after wounding. Little signal
was detected near the subdermal musculature of the panniculus
carnosus, and no signal was detected in the muscle (data not
shown). At day 37 after wounding (Fig 3B), MMP-13 mRNA
was predominantly detected in ¢broblasts that associated with
deep dermis, muscle, and fascia. In addition, some signal was
also observed within the muscle of the panniculus carnosus
(Fig 3C, D), particularly in those cells migrating toward the
wound center. Only selected muscle cells were positive for
MMP-13. The patterns of both MMP-13 and luciferase (data
not shown) expression in FEL and scalpel wounds were
indistinguishable. No signal was detected in adjacent, serial
sections that were reacted with sense probe (data not shown).
MMP-13 expression in FEL wounds To con¢rm that the
MMP-13 expression during the wound repair process was
correlated with the MMP-13 mRNA transcription, we did immu-
nostaining for MMP-13 with FEL wound tissues. As shown in
Fig 4(A, B), at day 15 after wounding there was more extensive
MMP-13 expression near the epidermis than the middle of the
dermis. At day 37 (Fig 4C, D), most of the MMP-13-positive
cells were located in the deep dermis.
Histologic studies for collagen To assess collagen deposition,
the wound areas were sampled at di¡erent time points after
laser irradiation and scalpel incision and ¢xed in 4%
paraformaldehyde. Tissue sections were stained with Masson’s
trichrome to contrast collagen. As shown in Fig 5, at days 10
and 36 after wounding, the scalpel incisions appeared to have
much more collagen organization in the wound site than did
the FEL wound, suggesting that the scalpel incisions had healed
more rapidly. By day 45 after injury, the collagen density in FEL
and scalpel incisions appeared similar (Fig 5E, F), suggesting that
the physical strength of FEL and scalpel wounds would be
comparable. Consistent with previous observations (Edwards
et al, 1994), there was essentially no evidence of collateral thermal
damage at the margins of the FEL wounds at any of the time
points.
Figure1. Relative tensile strengths of healing incisions versus time.
Values at each time point represent the mean ratios of tensile strength of
paired FEL and scalpel wounds in individual, wild-type animals at each
time point (N¼ 5). Asterisks indicate a signi¢cant di¡erence in tensile
strength between FEL and scalpel wounds at that time point (po0.05,
po0.01). At days 10, 14, and 22, the FEL wounds show lower tensile
strength than scalpel incisions. At days 45 and 62 tensile strength was not
signi¢cantly di¡erent between the two lesions.
Figure 2. Patterns of MMP-13 promoter activity within FEL and
scalpel wounds in transgenic mice. The signals of luciferase biolumi-
nescence from the FEL and scalpel wound area of a representative mouse
were quanti¢ed, and the total photon counts were plotted with respect to
days after injury. The signals of luciferase from FEL and scalpel wounds
showed a similar temporal pattern of promoter activity. (A) MMP-13 pro-
moter activity in MMP-13 transgenic mice. There were two phases of
MMP-13 promoter activity: the ¢rst peak was at around 15 d, and the sec-
ond peak was at 37 d after injury. FEL incisions showed higher luciferase
activity than scalpel incisions during wound healing. (B) Collagen promo-
ter activity in COL1A2 transgenic mice. The peak collagen promoter activ-
ity was at 10 d after injury, and the signal decreased dramatically at 14 d
after injury. After 18 d, almost no signal was detected. Data from additional
animals are available (supplementary ¢gure).
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In£ammatory response to incisions Tissue sections from FEL
and scalpel incisions at days 2 and 7 postwounding were
immunostained for macrophages to estimate the in£ammatory
response after FEL and scalpel incision. As shown in Fig 6,
macrophages were more abundant at day 7 than day 2 after
injury in both types of wounds, and more macrophages were
present in FEL incisions than scalpel incisions at both time points.
MMP-13 stimulation by a growth factor To con¢rm that the
higher MMP-13 promoter activity in FEL wounds could be
stimulated at least in part by growth factors from in£ammatory
cells such as macrophages, we injected bFGF subcutaneously into
the intact dorsal skin in transgenic mice (N¼ 6) and imaged the
luciferase bioluminescence on successive days. As shown in
Fig 7(A), at day 2 after injection we did not detect a di¡erence
between control and bFGF injection sites; however, by day 3
after injection (Fig 7B), the signals in bFGF injection sites were
much higher than day 2 and control. At day 4 (Fig 7C), the
signals at injection sites became weaker than day 3.
DISCUSSION
Currently, the CO2 laser is the most commonly used laser for
tissue ablation and incision, and it has been proved to be a reliable
tool for a variety of surgical procedures.The thermal damage pro-
duced by the laser to the tissue ablation area, however, leads to a
delay in wound healing (Bryant et al, 1998). A variety of techni-
ques have been studied or developed to minimize this thermal
damage to surrounding tissues, including the use of a reduced
spot size, microspot micromanipulators for precise beam delivery,
computer-controlled beam delivery, local cooling, and modi¢ca-
tion to the energy pulse duration and repetition rate (Sanders and
Reinisch, 2000).The FEL has been shown to produce less thermal
damage than standard shuttered continuous-wavelength CO2
lasers. Because the micropulsed infrared energy emitted by the
FEL is targeted to speci¢c dermal proteins rather than nonspeci¢c
water absorption, it can reduce collateral thermal damage
(Edwards et al, 1994). This may permit more rapid wound repair.
Wound repair is a succession of overlapping biochemical and
cellular events that result, in the best of circumstances, in the re-
storation of both the structural and functional integrity of the da-
maged tissue (Davidson and Benn, 1996). Unencumbered, these
wound repair processes follow a speci¢c time sequence and can
be temporally categorized into three major groups: in£ammation,
tissue formation, and tissue remodeling (Clark and Henson, 1996).
The MMP are a family of structurally related zinc-dependent
neutral proteinases. They play important roles in various normal
physiologic situations such as embryonic development, angiogen-
esis, parturition, ovulation, and remodeling of scar tissue, and
pathologic conditions such as rheumatoid arthritis, tumor cell in-
vasion, and metastasis (Henney et al, 1991; Stetler-Stevenson et al,
1993; Mao et al, 1999). Collagenase-3 (MMP-13) is the predomi-
nant collagenase in the mouse (Balbin et al, 2000; 2001). It is a
member of both the MMP family of enzymes and the collage-
nase subfamily of MMP, which includes three members (i.e.,
MMP-1, MMP-8, and MMP-13) with an overall sequence
Figure 3. Localization of MMP-13 mRNA in FEL wounds from
transgenic mice. Sections of mouse skin at 15 d and 37 d after injury were
hybridized with digoxigenin-labeled antisense riboprobes derived from
mouse MMP-13 cDNA and counterstained with fast green. EP, epidermis;
W, wound site. (A) At 15 d during the ¢rst expression peak of MMP-13
promoter activity, MMP-13 mRNAwas localized to the dermal ¢broblasts
near the epidermis (arrow). (B) At 37 d, during the second peak of MMP-13
promoter activity, in situ hybridization showed the bulk of MMP-13 ex-
pression had shifted to the deep dermis, muscle, and fascia. Panels C and
D illustrate regions of the regenerating panniculus carnosus that expressed
MMP-13 mRNA at day 37 after injury. MMP-13 signals were detected on
cells on the tip of migrating muscle as well as muscle cells behind the lead-
ing edge (panel D). Panel E is the negative control. Panel F is a high magni-
¢cation view of the upper dermis in panel A. A spindle-shaped ¢broblastic
cell with positive signal is indicated by the arrow. Scale bars: A, B, E, 50 mm;
C, D, F, 10 mm.
Figure 4. Immunostaining of MMP-13 in the FEL wound. Sections
of FEL incisional tissues at day 15 (A, B) and day 37 (C, D) postinjury were
stained with polyclonal anti-MMP-13 antibody. In the IgG control (E),
there was no detectable labeling for MMP-13. At day 15 (A), there was
a greater extent of MMP-13 expression near the epidermis. At 37 d
(C, shown at higher magni¢cation in D), most MMP-13 expression was
located in the deep dermis. Scale bars: A, C, 50 mm; B, D, 10 mm.
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homology of 55%.They are the principal neutral proteinases cap-
able of degrading native ¢brillar collagens in the extracellular
space (Ravanti et al, 1999a; 1999b). Biochemical characterization
of recombinant human MMP-13 has shown that this enzyme
cleaves type II collagen about 6-fold more e¡ectively than types
I and III collagens, and it displays a 40-fold stronger gelatinase
activity than MMP-1 or MMP-8 (Knauper et al, 1996). MMP-13
is expressed in situations in which either rapid or e¡ective remo-
deling (Johansson et al, 1997; Stahle-Backdahl et al, 1997) or exces-
sive degradation of collagenous extracellular matrices takes place
(Mitchell et al, 1996; Reboul et al, 1996).
Collagenase expression has been strongly implicated in not
only matrix remodeling but epithelial migration (Madlener,
1998). MMP-13 is expressed by normal and transformed murine
keratinocytes (Netzel-Arnett et al, 2002;Warmka et al, 2002), and
MMP-13 expression is further ampli¢ed by in£ammatory cyto-
kines and growth factors (Netzel-Arnett et al, 2002). In human
epidermis, MMP-1 is prominently expressed at the leading edge
of migrating epidermis (Pilcher et al, 1997), and collagenase has
similarly been localized in murine excisional wounds during the
¢rst few days of wound closure (Madlener, 1998). In human
wounds, MMP-13 expression is reported to occur only in the
connective tissue of chronic wounds (Vaalamo et al, 1997). Our
studies used an incisional model that minimizes the requirement
for epidermal resurfacing, and it was clear that the connective tis-
sue compartment was the dominant source of MMP-13 expres-
sion during the middle and late phases of wound repair. Low
level, early expression of MMP-13 in the epidermis could not be
excluded with our data.
To study the role of mouse MMP-13 gene in cutaneous wound
healing, we have generated a transgenic mouse line in which the
MMP-13 promoter directs the expression of luciferase reporter
gene with the same temporal and spatial pattern as the endogen-
ous MMP-13 gene and contains information essential for directing
Figure 5. Connective tissue organization in laser and surgical inci-
sions. Sections of scalpel (A, B, C) and FEL (D, E, F) incisional wounds
from day 10 (A, D), 36 (B, E), and 45 (C, F) postinjury were stained with
Masson’s trichrome. Scalpel incisions show more intense collagen staining
and lower cellularity than FELwounds at days 10, 36, and 45, but by day 45
the amount of collagen appeared similar between FEL and scalpel incisions
(C, F). Scale bars: 100 mm.
Figure 6. Detection of macrophages in FEL and scalpel wounds.
Sections of FEL (A, B) and scalpel (C, D) incisional tissues at day 2 (A,
C) and day 7 (B, D) postinjury were stained with monoclonal antima-
crophage antibody. In the IgG control (E), there was no detectable labeling
for macrophage. There were more macrophages in FEL (A, B) than scalpel
(C, D) wound areas at the same time point. Panel F shows the mean macro-
phage numbers per high power ¢eld (N¼10) for the FEL and scalpel
wounds at days 2 and 7. Scale bars: 100 mm.
Figure 7. MMP-13 stimulation by bFGF in transgenic mice. A mix-
ture of 2 mg (c) or 10 mg (d) of bFGF in 10 mL PBS and 50 mL pluronic gel
were subcutaneously injected into intact dorsal skin. The controls (a, b)
were given with a mixture of water and pluronic gel. At 2 d after injection
(A), there was no detectable signal in the bFGF injection sites. At 3 d after
injection (B), bFGF injection sites (c, d) showed higher signals than controls
(a, b), and at 4 d (C) the signals were weaker than day 3. There was a high
level of constitutive MMP-13 promoter activity in the tail, snout, and
paws.
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tissue-speci¢c expression. In this study we compared the wound
healing of FEL and scalpel incisions and tried to correlate wound
healing with MMP-13 expression by visualizing luciferase activ-
ity in transgenic mice.
To compare the wound healing of FEL and scalpel incisions,
we determined the tensile strengths of FEL and scalpel wounds.
Preliminary studies in the rat showed that FEL incisions had
greater strength than surgical incisions at 6.1 and 6.45 mm,
whereas the CO2 laser was slightly inferior to the scalpel
(Davidson et al, 2001). In contrast, the results in the thinner skin
of the mouse showed that the tensile strength of scalpel incision
increased more rapidly than that of the FEL incision at days 10, 14,
and 22 after injury with selected parameters (6.1 mm, 30 Hz, 20
mJ). This di¡erence suggested that the FEL surgery resulted in
some alteration to the adjacent tissue and caused a delay in wound
healing. The response of cutaneous tissue to FEL radiation may
vary substantially as a function of species, skin thickness, and laser
operating parameters. It is well known that the conventional laser
as used in cutaneous surgery will produce direct e¡ects of thermal
energy penetrating to adjacent tissues. Thermally denatured con-
nective tissue may be a barrier to reorganization of the wound
site by newly formed granulation tissue (Bryant et al, 1998). The
delay in wound healing might also be explained by an increased
burden of tissue debris whose degradation requires the prolonged
activation of in£ammatory cells.There was no histologic evidence
of thermal denaturation, however, and wounds incised with the
FEL at 6.1 mm showed little thermocoagulation of dermal vascu-
lature.There were more macrophages in the provisional matrix or
granulation tissue of FEL incisions at days 2 and 7 after injury,
suggesting that the FEL incision had a prolonged in£ammatory
process. It is possible that a greater extent of macrophage activa-
tion induced higher MMP-13 expression by ¢broblasts in granu-
lation tissue due to cytokine release. Although the identity of this
inducing factor is not certain, cytokines such as tumor necrosis
factor a, interleukin-1, epidermal growth factor, ¢broblast
growth factor, and platelet-derived growth factor can stimulate
MMP-13 expression in cultured ¢broblasts (Borden et al, 1996;
Ravanti et al, 1999a), and macrophages can secrete such signal mo-
lecules (Vaes et al, 1980; Dayer et al, 1985). As shown in Fig 7, the
induction of MMP-13 by bFGF in our transgenic mice provided
direct evidence that at least one growth factor, bFGF, can stimulate
cutaneous MMP-13 expression in vivo. bFGF is a chemoattrac-
tant for numerous cell types, a potent mitogen for angiogenesis,
and an activator of wound contraction. The induction of MMP-
13 expression at the wound site may amplify collagen degradation
and reduce collagen deposition during the early phase of wound
healing, thus reducing the physical strength of the wound.
Although collagen gene expression was higher in FEL wounds,
collagen deposition was reduced. Exuberant collagen deposition
is not always bene¢cial. The reduced collagen deposition during
the early phase of wound healing after FEL surgery may decrease
the possibility of hypertrophic scarring and may be bene¢cial.
Hypertrophic scar and keloids, which may cause severe functional
and cosmetic problems, are characterized by an overabundant ex-
tracellular matrix, including dermal collagen (Niessen et al, 2001).
It was evident that luciferase/MMP-13 expression in FEL inci-
sions was higher than in scalpel incisions through most of the
repair process, indicating a more potent, aggressive ¢broblast re-
sponse. As ¢broblasts migrate into the wound, they participate in
collagen remodeling, a process that is dependent on both contin-
ued collagen synthesis and collagen catabolism.The synthesis and
assembly of collagen ¢bers is required for the gradual gain in ten-
sile strength with progressive formation of larger collagen bun-
dles and an alteration in intermolecular crosslinks (Clark and
Henson, 1996). The arrangement and distribution of collagen ¢-
bers in the wound/scar, however, changes dramatically during the
course of wound healing. The degradation of wound collagen is
controlled by a variety of collagenases, including MMP-13 (Stan-
ton et al, 2002). This ¢nding suggests a more intense tissue remo-
deling in FEL incisions; however, the expression kinetics of FEL
and scalpel incisions were parallel.We suggest that MMP-13 ex-
pression, indicated by luciferase in our transgenic mice, may be
correlated to somewhat elevated tissue damage. This was sup-
ported by the fact that there was an inverse correlation between
the tensile strength of wound skin and luciferase activity at the
early phase of wound healing. MMP-13 promoter activity as vi-
sualized by luciferase bioluminescence appears to be a valuable
surrogate marker for the extent of wound remodeling, and it
can be used to investigate the e¡ects of laser radiation and laser-
induced collateral thermal damage. It was clear that there were
two MMP-13 expression peaks during wound healing, and the
MMP-13 expression by ¢broblasts was located to di¡erent
regions of the wound at di¡erent stages of the repair process.
During the early peak, MMP-13 mRNA localized to dermal
¢broblasts near the epidermis, whereas at day 37 the expression
of MMP-13 was located near the deep dermis, muscle, and fascia.
This observation shows that healing of mouse skin is a biphasic
process, with two distinct remodeling events. Immunostaining
for MMP-13 showed that MMP-13 expression was correlated
with the MMP-13 mRNA transcription. Our previous studies
showed that the most prevalent expression of luciferase and
MMP-13 was in the dermal ¢broblasts at the wound margin at
the early phase of wound repair (Wu et al, 2002). The expression
of MMP-13 by ¢broblasts in the surrounding dermis suggested
that this form of collagenase may facilitate the migration of these
cells into the wound area. Normal ¢broblasts are embedded in a
¢brillar collagen-rich matrix. During acute injury, ¢broblast in-
vasion into granulation tissue is likely to involve the production
of matrix-degrading proteinases (Giannelli et al, 1997), permitting
release of these cells from local sites within the tissue. Neovascu-
larization of wounds occurs simultaneously with collagen degra-
dation and ¢broplasia by capillary buds sprouting from blood
vessels adjacent to the wound and extending into the wound
space. The process of capillary formation (angiogenesis) has been
studied in the usually avascular cornea, and the capillary endothe-
lial cells grown in vitro release plasminogen activator and collage-
nase in response to angiogenic stimuli (Kalebic et al, 1983). As
MMP-13 was expressed by ¢broblasts near the epidermis,
MMP-13 may also contribute to re-epithelialization. Although
the epithelial cells did not express MMP-13, collagenase is re-
quired for the migration of keratinocytes (Pilcher et al, 1997).
The second peak of expression suggests that MMP-13 is also
involved in long-term collagen remodeling and skeletal muscle
repair. It appeared that regenerating muscle ¢bers migrating
towards the center of the wound were active in the second phase
of MMP-13 expression. This implies that MMP-13 may also par-
ticipate in muscle repair during long-term scar remodeling.
In summary, we have compared the wound healing of FEL
and scalpel incisions and visualized the MMP-13 promoter activ-
ity during FEL and scalpel incisional wounds in vivo. The FEL-
induced lesions at a wavelength of 6.1 mm showed more luciferase
activity than scalpel wounds, and the tensile strength of FEL in-
cisions was weaker than scalpel incisions at the early phase of
wound healing.This suggests that the luciferase/MMP-13 activity
in our transgenic mice may correlate with the extent of damage
to the wound, and luciferase activity may be a valuable indicator
of the extent of wound remodeling that can be used to investi-
gate the e¡ect of laser radiation and collateral thermal damage.
MMP-13 was involved in a series of coordinated events during
wound healing.We speculate that the elevated MMP-13 expres-
sion in FEL incisions may be bene¢cial for better collagen de-
position, remodeling, and scar reduction.
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